Don’t miss an exclusive opportunity to hear from Dr. Cheilonda Johnson, a pulmonologist and expert in autoimmune-related interstitial lung disease (ILD) at the University of Pennsylvania and member of TMA’s Medical Advisory Board. Dr. Johnson’s groundbreaking research focuses on understanding the clinical and genetic factors behind autoimmune-ILD, a serious condition often associated with myositis.
In this webinar, Dr. Johnson will share insights from her recent pilot project funded by TMA, which identified key genetic markers linked to ILD in myositis patients. This work, which includes a unique lung tissue sample database, reveals critical information on how myositis genes can predict not only who is at risk for ILD, but also the severity of the disease. Dr. Johnson will discuss these and other findings of her research and what they mean for advancing treatments and improving outcomes for myositis patients.
This is a must-attend event for anyone affected by myositis, researchers, and healthcare providers. Register today to learn about the latest research and how it’s paving the way for better care and hope for the future!